Total Payments
$3,549
2024 Payments
$15.02
Companies
21
Transactions
217
Medicare Patients
2,637
Medicare Billing
$236,323
Payment Breakdown by Category
Food & Beverage$3,294 (92.8%)
Other$250.00 (7.0%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,294 | 215 | 92.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 1 | 7.0% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $636.10 | 26 | $0 (2021) |
| GlaxoSmithKline, LLC. | $586.55 | 36 | $0 (2018) |
| Novo Nordisk Inc | $556.47 | 47 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $375.52 | 10 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $271.44 | 13 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $241.28 | 17 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $210.73 | 21 | $0 (2017) |
| Lilly USA, LLC | $170.55 | 12 | $0 (2018) |
| PFIZER INC. | $105.20 | 7 | $0 (2018) |
| Purdue Pharma L.P. | $77.32 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.02 | 1 | CONMED Corporation ($15.02) |
| 2021 | $12.93 | 1 | AstraZeneca Pharmaceuticals LP ($12.93) |
| 2018 | $871.92 | 83 | Novo Nordisk Inc ($176.08) |
| 2017 | $2,649 | 132 | AstraZeneca Pharmaceuticals LP ($493.41) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | CONMED Corporation | VISICLEAR (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: GENERAL SURGERY | ||||||
| 03/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: Diabetes | ||||||
| 10/15/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Diabetes | ||||||
| 10/12/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Diabetes | ||||||
| 07/31/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 07/26/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Diabetes | ||||||
| 07/19/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Diabetes | ||||||
| 07/17/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 07/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2018 | GlaxoSmithKline, LLC. | BREO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug), FIASP | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Diabetes | ||||||
| 06/29/2018 | Collegium Pharmaceutical, Inc. | XTAMPZAER (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: Opioid Analgesic | ||||||
| 06/29/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: Diabetes | ||||||
| 06/28/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: DIABETES | ||||||
| 06/27/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Cardiology | ||||||
| 06/26/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 06/26/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2018 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 663 | 805 | $237,979 | $73,793 |
| 2022 | 9 | 681 | 856 | $239,466 | $73,959 |
| 2021 | 10 | 609 | 722 | $186,240 | $49,404 |
| 2020 | 10 | 684 | 792 | $82,110 | $39,167 |
Total Patients
2,637
Total Services
3,175
Medicare Billing
$236,323
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 297 | $118,800 | $25,262 | 21.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 37 | 37 | $17,980 | $10,385 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $17,082 | $10,270 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 156 | $48,048 | $10,080 | 21.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 34 | 34 | $12,342 | $6,099 | 49.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $4,929 | $3,812 | 77.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $6,994 | $2,317 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 61 | $3,538 | $2,005 | 56.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $4,788 | $1,831 | 38.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 51 | 51 | $3,366 | $1,676 | 49.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 16 | $112.00 | $54.56 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 323 | $132,164 | $28,438 | 21.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 53 | 53 | $15,476 | $14,771 | 95.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 191 | $58,828 | $11,986 | 20.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 54 | 54 | $12,636 | $7,653 | 60.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 67 | $6,231 | $4,501 | 72.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $5,814 | $2,244 | 38.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 66 | 66 | $4,356 | $2,153 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 66 | $3,828 | $2,149 | 56.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 19 | $133.00 | $65.34 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 213 | $82,980 | $19,555 | 23.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 209 | 269 | $71,572 | $17,537 | 24.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 34 | 34 | $10,416 | $4,245 | 40.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 58 | 59 | $5,441 | $3,777 | 69.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $6,002 | $1,559 | 26.0% |
About Dr. Anna Chen, MD
Dr. Anna Chen, MD is a Family Medicine healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871690495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Chen, MD has received a total of $3,549 in payments from pharmaceutical and medical device companies, with $15.02 received in 2024. These payments were reported across 217 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,294).
As a Medicare-enrolled provider, Chen has provided services to 2,637 Medicare beneficiaries, totaling 3,175 services with total Medicare billing of $236,323. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cherry Hill, NJ
- Active Since 09/17/2006
- Last Updated 02/18/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871690495
Products in Payments
- FARXIGA (Drug) $351.16
- BREO (Drug) $288.10
- SOLIQUA (Drug) $277.40
- Victoza (Drug) $260.27
- Tresiba (Drug) $196.28
- INVOKANA (Drug) $161.10
- TRULICITY (Drug) $144.14
- JARDIANCE (Drug) $129.32
- INCRUSE (Drug) $124.08
- XARELTO (Drug) $110.34
- JANUVIA (Drug) $105.49
- SYMBICORT (Drug) $98.03
- BEVESPI AEROSPHERE (Drug) $94.75
- BYDUREON (Drug) $92.16
- ASMANEX (Drug) $83.43
- MYDAYIS (Drug) $76.22
- PRALUENT (Drug) $68.86
- ANORO (Drug) $66.79
- CHANTIX (Drug) $63.62
- Trintellix (Drug) $63.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cherry Hill
Joseph Cavallaro, D.o, D.O
Family Medicine — Payments: $17,209
Family Medicine $17,209
Dr. Bonnie Levin, D.o, D.O
Family Medicine — Payments: $16,700
Family Medicine $16,700
Dr. Loretta Mueller, D.o, D.O
Family Medicine — Payments: $11,465
Family Medicine $11,465
Dr. Peter Kelly, D.o, D.O
Family Medicine — Payments: $6,424
Family Medicine $6,424
Dr. Cathleen Finan, D.o, D.O
Family Medicine — Payments: $6,203
Family Medicine $6,203
Dr. Justin Schweitzer, D.o, D.O
Family Medicine — Payments: $2,562
Family Medicine $2,562